{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:23:14Z","timestamp":1762424594714,"version":"build-2065373602"},"reference-count":69,"publisher":"IOP Publishing","issue":"6","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Phys. Eng. Express"],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Drug-Induced Liver Injury (DILI) is the leading cause of late-stage drug failure and withdrawal of medications from the market. This underscores the urgent need for new\n                    <jats:italic>in vitro<\/jats:italic>\n                    liver models that better recapitulate physiologically relevant conditions and provide controlled physical and biochemical parameters for drug toxicity testing. While advanced, complex liver-on-a-chip systems have been in use for some years, this study presents a simplified microfluidic model for technically comparing static and dynamic culture conditions using a hepatocyte-like cell line for drug toxicity testing. In this study, a dual-compartment microfluidic device comprising a dynamic flow channel and a cell culture chamber was designed to mimic the liver\u2019s microstructure. The device\u2019s membrane-based design enabled the investigation of cell-media interactions and replication of hepatic Disse space, with comparisons made between static and dynamic conditions. The chip design was evaluated using computational models of glucose consumption and shear stress, which yielded an optimal flow rate of 50 \u03bcL\/h. HepG2 cells cultured within the chip were assessed via live\/dead staining and metabolic function assays, including responses to three antiepileptic drugs at physiological doses, to evaluate hepatotoxicity. Under dynamic conditions, cell viability and function improved significantly, simulating a continuous supply of nutrients and oxygen, as well as mechanical shear stress signaling. Among the tested drugs, sodium valproate (500 \u03bcM) induced the least hepatotoxicity, whereas carbamazepine and phenytoin led to a \u223c60% reduction in hepatic function over one week. Although structurally and functionally less complex than existing liver-on-a-chip platforms, these findings suggest that this liver-chip platform is a simple yet useful tool for drug screening and hepatotoxicity assessment.\n                  <\/jats:p>","DOI":"10.1088\/2057-1976\/ae1506","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:47:38Z","timestamp":1761000458000},"page":"065038","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A microfluidic liver-like model for antiepileptic drugs hepatotoxicity evaluation"],"prefix":"10.1088","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-0719","authenticated-orcid":true,"given":"Ehsanollah","family":"Moradi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0817-1950","authenticated-orcid":false,"given":"Asieh","family":"Heirani-Tabasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-7052","authenticated-orcid":true,"given":"Mohammad Adel","family":"Ghiass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-1237","authenticated-orcid":true,"given":"Mehran","family":"Solati-Hashjin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"bpexae1506bib1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","type":"journal-article","article-title":"Drug induced liver injury - a 2023 update","volume":"26","author":"Allison","year":"2023","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"bpexae1506bib2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","type":"journal-article","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"key":"bpexae1506bib3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70002","type":"journal-article","article-title":"Drug-induced liver injury associated with emerging cancer therapies","volume":"45","author":"Chodup","year":"2025","journal-title":"Liver Int"},{"key":"bpexae1506bib4","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/ijms22062954","type":"journal-article","article-title":"Idiosyncratic drug-induced liver injury: mechanistic and clinical challenges","volume":"22","author":"Jee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"bpexae1506bib5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cnc.2022.04.007","type":"journal-article","article-title":"Drug-induced liver injury","volume":"34","author":"McAtee","year":"2022","journal-title":"Crit Care Nurs Clin North Am"},{"key":"bpexae1506bib6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jhep.2021.12.013","type":"journal-article","article-title":"Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study","volume":"76","author":"Chalasani","year":"2022","journal-title":"J Hepatol"},{"key":"bpexae1506bib7","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2022.103967","type":"journal-article","article-title":"Valproic acid induced liver injury: an insight into molecular toxicological mechanism","volume":"95","author":"Ezhilarasan","year":"2022","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"bpexae1506bib8","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2020.100580","type":"journal-article","article-title":"Drug-induced liver injury in critically Ill children taking antiepileptic drugs: a retrospective study","volume":"92","author":"Sridharan","year":"2020","journal-title":"Curr Ther Res Clin Exp"},{"key":"bpexae1506bib9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","type":"journal-article","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"bpexae1506bib10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","type":"journal-article","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"bpexae1506bib11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1586\/ern.09.136","type":"journal-article","article-title":"Drug interactions involving the new second- and third-generation antiepileptic drugs","volume":"10","author":"Johannessen Landmark","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"bpexae1506bib12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.seizure.2015.07.004","type":"journal-article","article-title":"The adverse event profile of levetiracetam: a meta-analysis on children and adults","volume":"31","author":"Verrotti","year":"2015","journal-title":"Seizure"},{"key":"bpexae1506bib13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","type":"journal-article","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol"},{"key":"bpexae1506bib14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40264-024-01486-6.","type":"journal-article","article-title":"Incidence of idiosyncratic drug-induced liver injury caused by prescription drugs","volume":"48","author":"Chen","year":"2024","journal-title":"Drug Saf"},{"key":"bpexae1506bib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15376516.2025.2459176","type":"journal-article","article-title":"Mechanisms involved in the valproic acid-induced hepatotoxicity: a comprehensive review","volume":"35","author":"Kadam","year":"2025","journal-title":"Toxicol Mech Methods"},{"key":"bpexae1506bib16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113890","type":"journal-article","article-title":"Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction","volume":"226","author":"Pal","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"bpexae1506bib17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.toxrep.2021.03.008","type":"journal-article","article-title":"Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats","volume":"8","author":"Osuntokun","year":"2021","journal-title":"Toxicol Rep"},{"key":"bpexae1506bib18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/03602532.2022.2064487","type":"journal-article","article-title":"In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation","volume":"54","author":"Mirahmad","year":"2022","journal-title":"Drug Metab Rev"},{"key":"bpexae1506bib19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1155271","type":"journal-article","article-title":"The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics","volume":"14","author":"Quint\u00e1s","year":"2023","journal-title":"Front Pharmacol"},{"key":"bpexae1506bib20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1124\/dmd.115.063370","type":"journal-article","article-title":"Carbamazepine-induced liver injury requires CYP3A-Mediated metabolism and glutathione depletion in rats","volume":"43","author":"Iida","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"bpexae1506bib21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/toxsci\/kft184","type":"journal-article","article-title":"A novel mouse model for phenytoin-induced liver injury: involvement of immune-related factors and P450-mediated metabolism","volume":"136","author":"Sasaki","year":"2013","journal-title":"Toxicol. Sci."},{"key":"bpexae1506bib22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/metabo13010134","type":"journal-article","article-title":"Therapeutic and toxic effects of valproic acid metabolites","volume":"13","author":"Shnayder","year":"2023","journal-title":"Metabolites"},{"key":"bpexae1506bib23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00204-020-02963-4","type":"journal-article","article-title":"Antidepressants- and antipsychotics-induced hepatotoxicity","volume":"95","author":"Todorovi\u0107 Vukoti\u0107","year":"2021","journal-title":"Arch. Toxicol."},{"key":"bpexae1506bib24","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","type":"journal-article","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"key":"bpexae1506bib25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111188","type":"journal-article","article-title":"Towards improved hepatocyte cultures: progress and limitations","volume":"138","author":"Ruo\u00df","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"bpexae1506bib26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/cells12111476","type":"journal-article","article-title":"Microphysiological models for mechanistic-based prediction of idiosyncratic DILI","volume":"12","author":"Stern","year":"2023","journal-title":"Cells"},{"key":"bpexae1506bib27","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100432","type":"journal-article","article-title":"Liver three-dimensional cellular models for high-throughput chemical testing","volume":"3","author":"Yang","year":"2023","journal-title":"Cell Rep Methods"},{"key":"bpexae1506bib28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114758","type":"journal-article","article-title":"State-of-the-art advancements in Liver-on-a-chip (LOC): integrated biosensors for LOC","volume":"218","author":"Liu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"bpexae1506bib29","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1039\/D2LC00307D","type":"journal-article","article-title":"Liver organ-on-chip models for toxicity studies and risk assessment","volume":"22","author":"Messelmani","year":"2022","journal-title":"Lab Chip"},{"key":"bpexae1506bib30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.actbio.2020.08.041","type":"journal-article","article-title":"Microfluidic organ-on-a-chip models of human liver tissue","volume":"116","author":"Moradi","year":"2020","journal-title":"Acta Biomater."},{"key":"bpexae1506bib31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/bios14090435","type":"journal-article","article-title":"Advanced Liver-on-a-Chip model for evaluating drug metabolism and hepatotoxicity","volume":"14","author":"Frojdenfal","year":"2024","journal-title":"Biosensors (Basel)"},{"key":"bpexae1506bib32","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1039\/D4AN00602J","type":"journal-article","article-title":"A pumpless liver-on-a-chip for drug hepatotoxicity analysis","volume":"149","author":"Jiao","year":"2024","journal-title":"Analyst"},{"key":"bpexae1506bib33","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/liv.14942","type":"journal-article","article-title":"Experimental liver models: from cell culture techniques to microfluidic organs-on-chip","volume":"41","author":"Polidoro","year":"2021","journal-title":"Liver Int"},{"key":"bpexae1506bib34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jbiosc.2023.10.006","type":"journal-article","article-title":"Coculture model of a liver sinusoidal endothelial cell barrier and HepG2\/C3a spheroids-on-chip in an advanced fluidic platform","volume":"137","author":"Messelmani","year":"2024","journal-title":"J. Biosci. Bioeng."},{"key":"bpexae1506bib35","doi-asserted-by":"publisher","first-page":"064108","DOI":"10.1063\/5.0172677","type":"journal-article","article-title":"Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction","volume":"17","author":"Wang","year":"2023","journal-title":"Biomicrofluidics"},{"key":"bpexae1506bib36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/bios12070445","type":"journal-article","article-title":"Liver acinus dynamic chip for assessment of drug-induced zonal hepatotoxicity","volume":"12","author":"Kwon","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"bpexae1506bib37","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.actbio.2023.09.022","type":"journal-article","article-title":"3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation","volume":"171","author":"Wesseler","year":"2023","journal-title":"Acta Biomater."},{"key":"bpexae1506bib38","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114292","type":"journal-article","article-title":"Convenient rapid prototyping microphysiological niche for mimicking liver native basement membrane: liver sinusoid on a chip","volume":"245","author":"Ebrahimi","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"bpexae1506bib39","doi-asserted-by":"publisher","first-page":"064103","DOI":"10.1063\/5.0170606","type":"journal-article","article-title":"A method to generate perfusable physiologic-like vascular channels within a liver-on-chip model","volume":"17","author":"Ferrari","year":"2023","journal-title":"Biomicrofluidics"},{"key":"bpexae1506bib40","doi-asserted-by":"publisher","DOI":"10.34133\/2021\/9871396","type":"journal-article","article-title":"Pulsed microfluid force-based on-chip modular fabrication for liver lobule-like 3D cellular models","volume":"2021","author":"Cui","year":"2021","journal-title":"Cyborg Bionic Syst"},{"key":"bpexae1506bib41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/ten.tea.2023.0212","type":"journal-article","article-title":"3D bioprinted liver-on-a-chip for drug cytotoxicity screening","volume":"30","author":"Huh","year":"2024","journal-title":"Tissue Eng. Part A"},{"key":"bpexae1506bib42","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/mi11121118","type":"journal-article","article-title":"A new 3D cultured liver chip and real-time monitoring system based on microfluidic technology","volume":"11","author":"Zhang","year":"2020","journal-title":"Micromachines (Basel)"},{"key":"bpexae1506bib43","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1126\/scitranslmed.aax5516","type":"journal-article","article-title":"Reproducing human and cross-species drug toxicities using a liver-chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"bpexae1506bib44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","type":"journal-article","article-title":"Performance assessment and economic analysis of a human liver-chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"bpexae1506bib45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/cts.12969","type":"journal-article","article-title":"Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation","volume":"14","author":"Rubiano","year":"2021","journal-title":"Clin Transl Sci"},{"key":"bpexae1506bib46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbiosy.2022.100054","type":"journal-article","article-title":"Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation","volume":"7","author":"Cox","year":"2022","journal-title":"Biomater Biosyst"},{"key":"bpexae1506bib47","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/bit.24912","type":"journal-article","article-title":"Analysis and comparison of oxygen consumption of HepG2 cells in a monolayer and three-dimensional high density cell culture by use of a matrigrid(R)","volume":"110","author":"Weise","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"bpexae1506bib48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1743-8977-7-36","type":"journal-article","article-title":"ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies","volume":"7","author":"Hinderliter","year":"2010","journal-title":"Part. Fibre Toxicol."},{"key":"bpexae1506bib49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/bit.25355","type":"journal-article","article-title":"Multiple approaches to predicting oxygen and glucose consumptions by HepG2 cells on porous scaffolds in an axial-flow bioreactor","volume":"112","author":"Podichetty","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"bpexae1506bib50","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1088\/1758-5090\/8\/1\/014101","type":"journal-article","article-title":"A liver-on-a-chip platform with bioprinted hepatic spheroids","volume":"8","author":"Nupura","year":"2016","journal-title":"Biofabrication"},{"key":"bpexae1506bib51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/ijms22010372","type":"journal-article","article-title":"Polycyclic aromatic hydrocarbons activate the aryl hydrocarbon receptor and the constitutive androstane receptor to regulate xenobiotic metabolism in human liver cells","volume":"22","author":"Goedtke","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"bpexae1506bib52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000545120","type":"journal-article","article-title":"In vitro assessment of drug adsorption profiles during hemoadsorption therapy","volume":"54(4-5)","author":"K\u00f6rtge","year":"2025","journal-title":"Blood Purif"},{"key":"bpexae1506bib53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1039\/C6LC01374K","type":"journal-article","article-title":"Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip","volume":"17","author":"Du","year":"2017","journal-title":"Lab Chip"},{"key":"bpexae1506bib54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1142\/S2339547815200034","type":"journal-article","article-title":"A novel low-volume two-chamber microfabricated platform for evaluating drug metabolism and toxicity","volume":"3","author":"Bale","year":"2015","journal-title":"Technology"},{"key":"bpexae1506bib55","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100432","type":"journal-article","article-title":"Liver three-dimensional cellular models for high-throughput chemical testing","volume":"3","author":"Yang","year":"2023","journal-title":"Cell Reports Methods"},{"key":"bpexae1506bib56","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1039\/D1BM01872H","type":"journal-article","article-title":"In vitro functional models for human liver diseases and drug screening: beyond animal testing","volume":"11","author":"Paradiso","year":"2023","journal-title":"Biomater. Sci."},{"key":"bpexae1506bib57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s43188-025-00289-w","type":"journal-article","article-title":"Advancing hepatotoxicity assessment: current advances and future directions","volume":"41","author":"Kim","year":"2025","journal-title":"Toxicological Research"},{"key":"bpexae1506bib58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/bit.25700","type":"journal-article","article-title":"Long term maintenance of a microfluidic 3D human liver sinusoid","volume":"113","author":"Prodanov","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"bpexae1506bib59","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/bit.25157","type":"journal-article","article-title":"Computational fluid model incorporating liver metabolic activities in perfusion bioreactor","volume":"111","author":"Hsu","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"bpexae1506bib60","doi-asserted-by":"publisher","first-page":"34113","DOI":"10.1063\/1.4922863","type":"journal-article","article-title":"On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro","volume":"9","author":"Jang","year":"2015","journal-title":"Biomicrofluidics"},{"key":"bpexae1506bib61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","type":"journal-article","article-title":"Drug-induced liver injury: interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"Journal of Hepatology"},{"key":"bpexae1506bib62","first-page":"844","type":"book","article-title":"56 - drug-induced liver injury","author":"Devarbhavi","year":"2018","edition":"7th Edition"},{"key":"bpexae1506bib63","first-page":"2","type":"book","article-title":"1 - Anatomy and cellular functions of the liver A2 - Sanyal, Arun J","author":"Qin","year":"2018","edition":"7th Edition"},{"key":"bpexae1506bib64","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","type":"journal-article","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"key":"bpexae1506bib65","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0090-9556(24)15168-9","type":"journal-article","article-title":"Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation1","volume":"28","author":"Cuttle","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"bpexae1506bib66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/PGPM.S108113","type":"journal-article","article-title":"CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment","volume":"11","author":"Silvado","year":"2018","journal-title":"Pharmgenomics Pers Med"},{"key":"bpexae1506bib67","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1600-0404.2008.01009.x","type":"journal-article","article-title":"Hepatotoxicity associated with antiepileptic drugs","volume":"118","author":"Bjornsson","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"bpexae1506bib68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/106002808902300102","type":"journal-article","article-title":"Phenytoin hepatotoxicity: a review of the literature","volume":"23","author":"Smythe","year":"1989","journal-title":"Dicp"},{"key":"bpexae1506bib69","doi-asserted-by":"publisher","first-page":"14528","DOI":"10.1038\/s41598-017-13848-5","type":"journal-article","article-title":"A perfusion incubator liver chip for 3D cell culture with application on chronic hepatotoxicity testing","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep."}],"container-title":["Biomedical Physics &amp; Engineering Express"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:19:35Z","timestamp":1762424375000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae1506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,6]]},"published-print":{"date-parts":[[2025,11,28]]}},"URL":"https:\/\/doi.org\/10.1088\/2057-1976\/ae1506","relation":{},"ISSN":["2057-1976"],"issn-type":[{"type":"electronic","value":"2057-1976"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"A microfluidic liver-like model for antiepileptic drugs hepatotoxicity evaluation","name":"article_title","label":"Article Title"},{"value":"Biomedical Physics & Engineering Express","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2025 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2025-07-24","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-10-20","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-11-06","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}